Civet SARS-CoV
Civet SARS-CoV is a strain of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) that was identified in civets, a type of small mammal native to Asia and Africa. This strain is significant because it is believed to have played a role in the SARS outbreak that occurred in the early 2000s.
Discovery and Identification
The Civet SARS-CoV was first identified in 2003 during the investigation of the SARS outbreak. Researchers found that the virus in civets was nearly identical to the virus found in humans, suggesting that civets could be an intermediate host for the virus. This discovery was crucial in understanding the zoonotic transmission of SARS-CoV.
Transmission
Civet SARS-CoV is thought to have been transmitted to humans through direct contact with infected civets or through the handling and consumption of civet meat. The virus is capable of zoonosis, meaning it can jump from animals to humans, which is a common characteristic of many coronaviruses.
Role in SARS Outbreak
The identification of Civet SARS-CoV helped scientists understand the origins of the SARS outbreak. It is believed that the virus originated in bats and was transmitted to civets, which then acted as an intermediate host before the virus was transmitted to humans. This zoonotic pathway is similar to other coronaviruses, such as MERS-CoV and SARS-CoV-2.
Prevention and Control
To prevent future outbreaks, measures were taken to control the trade and consumption of civets. In some regions, civet farms were closed, and the sale of civet meat was banned. These actions were part of broader efforts to control the spread of zoonotic diseases and to monitor wildlife that could potentially harbor dangerous viruses.
Research and Studies
Ongoing research continues to study the role of civets and other animals in the transmission of coronaviruses. Understanding the mechanisms of zoonotic transmission is essential for preventing future outbreaks and for developing strategies to combat emerging infectious diseases.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD